首页|非诺多泮抑制小鼠胸主动脉瘤的实验研究

非诺多泮抑制小鼠胸主动脉瘤的实验研究

扫码查看
原文链接
  • 万方数据
  • 维普
目的 探讨多巴胺一型受体激动剂非诺多泮(FNDP)是否对小鼠胸主动脉瘤(TAA)具有保护作用.方法 对 3周龄的雄性 C57BL/6J 小鼠采用 β-氨基丙腈(BAPN)复制TAA模型.25 只小鼠分为三组:对照组、BAPN组、BAPN+FNDP组(腹腔注射FNDP).统计TAA的发生率和生存率,观察胸主动脉的大体变化,弹力蛋白(Elastin)染色观察形态学改变.免疫组化法检测基质金属酶 2(MMP2)、基质金属酶9(MMP9)和 白细胞分化抗原68(CD68)的变化.明胶酶谱法检测MMP2 和MMP9 的活性.反转录聚合酶链式反应(RT-PCR)法检测多巴胺受体 1(D1DR)、多巴胺受体 2(D2DR)、多巴胺受体 3(D3DR)、多巴胺受体 5(D5DR)、白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)、α-平滑肌肌动蛋白(α-SMA)及平滑肌蛋白22α(SM22α)的mRNA表达情况.结果 与对照组相比,BAPN组有明显的TAA形成,胸主动脉壁弹力纤维紊乱与断裂,且D1DR和D5DR的mRNA水平均显著下降.与BAPN组相比,BAPN+FNDP组小鼠TAA的形成率和动脉瘤破裂率明显降低;胸主动脉壁的弹力纤维紊乱与断裂明显改善;胸主动脉壁内MMP2 和MMP9 的表达水平均显著下降,血清中MMP2 的酶活性显著降低;胸主动脉壁中巨噬细胞浸润显著降低,且IL-1β、IL-6、TNF-α和 MCP-1的mRNA水平均显著下降;α-SMA和SM22α mRNA表达水平无显著差异.结论 FNDP可抑制小鼠TAA的进展,有可能成为治疗TAA的一个潜在药物.
The repressing effect of fenoldopam on the development of thoracic aortic aneurysm in mice
Objective To investigate whether fenoldopam(FNDP)(an agonist of type 1 dopamine receptor)has a protective effect on thoracic aortic aneurysm(TAA)in mice.Methods Three-week-old male C57BL/6J mice were treated with β-aminopropionitrile(BAPN)to induce TAA.The mice were divided into three groups:the con-trol group,the BAPN group,and the BAPN+FNDP group(FNDP injected intraperitoneally).The incidence and survival rate of TAA were recorded.Gross anatomy of the whole aortae was observed.Elastin staining was per-formed to assess morphological change,while immunohistochemistry was employed to evaluate the expressions of matrix metalloproteinase 2(MMP2),matrix metalloproteinase 9(MMP9)and cluster of differentiation 68(CD68)respectively.Gelatin zymography was conducted to assess MMP2 and MMP9 activity.Reverse transcription-poly-merase chain reaction(RT-PCR)was performed to measure the mRNA expression levels of dopamine receptor D1(D1DR),dopamine receptor d2(D2DR),dopamine receptor d3(D3DR),dopamine receptor d5(D5DR),in-terleukin-1β(IL-1β),interleukin-6(IL-6),tumour necrosis factor-α(TNF-α),monocyte chemoattractant pro-tein-1(MCP-1),alpha-smooth muscle actin(α-SMA)and smooth muscle protein 22-alpha(SM22α).Results Compared to the control group,the BAPN group exhibited significant formation of TAA.Elastic fiber disruption was also observed in the thoracic aortic wall,along with a significant decrease in the mRNA levels of D1DR and D5DR.The BAPN+FNDP group showed a significant reduction in the incidence of TAA formation and the rate of aneu-rysm rupture compared to the BAPN group.The disruption and rupture of elastic fibers in the thoracic aortic wall were significantly improved in the BAPN+FNDP group.The levels of MMP2 and MMP9 in the thoracic aortic wall significantly decreased,and the enzymatic activity of MMP2 in the serum was significantly reduced.Moreover,macrophage infiltration in the thoracic aortic wall was significantly reduced and the mRNA levels of IL-1β,IL-6,TNF-α and MCP-1 also significantly decreased after FNDP treatment.There was no statistically significant differ-ence in the mRNA levels of α-SMA and SM22α.Conclusion FNDP shows an inhibitory effect on TAA progres-sion in mice,suggesting a potential of FNDP as a therapeutic agent for TAA.

thoracic aortic aneurysmdopamine receptorsfenoldopammacrophagesinflammationextracellu-lar matrix degradation

周莹、武栗妃、杜文静、曹济民

展开 >

山西医科大学细胞生理学教育部重点实验室,太原 030000

山西医科大学生理学系,太原 030000

山西医科大学病理生理学系,太原 030000

中国医学科学院基础医学研究所细胞生物学系医学分子生物学国家重点实验室,北京 100000

展开 >

胸主动脉瘤 多巴胺受体 非诺多泮 巨噬细胞 炎症 基质降解

国家自然科学基金国家自然科学基金国家自然科学基金山西省教育厅"1331工程"提质增效建设计划山西省基础研究计划

8217052381670313U22A60081331KFC20210302124412

2024

10.19405/j.cnki.issn1000-1492.2024.04.002

安徽医科大学学报
安徽医科大学

安徽医科大学学报

CSTPCD北大核心
影响因子：1.095
ISSN：1000-1492
年,卷(期)：2024.59(4)
  • 15